In all, the ACP5 missense mutations associated with SPENCD generally lead to improper conformation, inefficient glycosylation, interrupted intracellular trafficking, and limited secretion. The gene discussed is ACP5; the disease is Spondyloenchondrodysplasia with immune dysregulation.